Koers BioElectronics Corporation Other OTC
Aandelen
BIEL
US09062H1086
Geavanceerde medische apparatuur & technologie
Omzet 2020 | 830K 770K | Omzet 2021 | 1,61 mln. 1,49 mln. | Marktkapitalisatie | 25,6 mln. 23,77 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -1 mln. -929K | Nettowinst (verlies) 2021 | - 0 | EV/omzet 2020 | 53,6 x |
Nettoschuld 2020 | 13,07 mln. 12,14 mln. | Nettoschuld 2021 | 13,34 mln. 12,39 mln. | EV/omzet 2021 | 24,2 x |
K/w-verhouding 2020 |
-26,5
x | K/w-verhouding 2021 |
-95,5
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kelly A. Whelan
CEO | Chief Executive Officer | - | 15-11-19 |
Keith E. Nalepka
SAM | Sales & Marketing | - | 01-09-17 |
John M. Martinez
PRN | Corporate Officer/Principal | - | 01-04-02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 83 | 15-06-20 | |
Keith E. Nalepka
SAM | Sales & Marketing | - | 01-09-17 |
Kelly A. Whelan
CEO | Chief Executive Officer | - | 15-11-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,06% | 218 mld. | |
+6,94% | 184 mld. | |
+13,54% | 135 mld. | |
-0,27% | 62,38 mld. | |
+11,59% | 51,37 mld. | |
+7,76% | 50,9 mld. | |
+1,14% | 40,87 mld. | |
+3,21% | 36,28 mld. | |
+26,11% | 31,88 mld. |